- Round ID
- FR-00479
- Stage
- Series B
- Round name
- Series B
- Amount
- $100m+
Dated funding evidence
Ori Biotech
Series B · $100m+ · 2022-01-01
Reported round$100m+Series B
- Disclosure date
- 2022-01-01
- Reported currency
- USD
- Companies House
- 09757696
- Evidence sources
- 1
Company
Ori BiotechCH 097576962022-01-01Series B$100m+
Resolved investor records
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Novalis LifeSciences
- Other investors
- Puhua Capital, Chimera Abu Dhabi
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-15
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.